Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/1999
08/19/1999WO1999041240A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors
08/19/1999WO1999041224A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
08/19/1999WO1999040940A1 Ligands of the cd47 antigen, agents binding the ligands of the cd47 antigen and uses thereof
08/19/1999WO1999040939A1 Method for the prevention and treatment of a type i hypersensitivity disorder
08/19/1999WO1999040938A2 Vaccines comprising interleukin-12 and herpes simplex viral antigen
08/19/1999WO1999040935A1 Novel preventives/remedies for immunopathy
08/19/1999WO1999040921A2 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
08/19/1999WO1999040914A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
08/19/1999WO1999040913A1 Chemical compounds
08/19/1999WO1999040909A1 Method for modulating macrophage activation
08/19/1999WO1999030741A3 Agent for gene therapy of tumor, neurodegenerative, cardiovascular and autoimmune diseases
08/19/1999WO1999024024A3 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists
08/19/1999WO1999001416A3 1-amino-alkylcyclohexane nmda receptor antagonists
08/19/1999DE19859526A1 Pharmaceutical composition, especially for gene transfer and therapy
08/19/1999DE19806348A1 3,4-Dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln 3,4-dihydroquinoline derivatives and their use in medicaments
08/19/1999CA2632106A1 Method for modulating macrophage activation
08/19/1999CA2321277A1 Derivatised antibodies with exposed carbohydrate chains capable of binding to immobilised igg
08/19/1999CA2321105A1 Human short-chain tnf-receptor family protein
08/19/1999CA2320960A1 Optimization of immunomodulatory properties of genetic vaccines
08/19/1999CA2320911A1 Glucocorticoid-selective anti-inflammatory agents
08/19/1999CA2320626A1 Genetic vaccine vector engineering
08/19/1999CA2320512A1 Novel preventives/remedies for immunopathy
08/19/1999CA2320431A1 Targeting of genetic vaccine vectors
08/19/1999CA2320427A1 Human receptor proteins
08/19/1999CA2320383A1 Hiv chemokines
08/19/1999CA2320104A1 Method for the prevention and treatment of a type i hypersensitivity disorder
08/19/1999CA2320044A1 Treatment of multiple sclerosis using cop-1 and th2-enhancing cytokines
08/19/1999CA2320041A1 Vaccines comprising interleukin-12 and herpes simplex viral antigen
08/19/1999CA2319173A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
08/19/1999CA2319082A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
08/19/1999CA2318966A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
08/19/1999CA2318957A1 Antagonists of gonadotropin releasing hormone
08/19/1999CA2317456A1 Chemical compounds
08/18/1999EP0935663A2 Multi-functional chimeric hematopoietic receptor agonists
08/18/1999EP0935660A1 Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof
08/18/1999EP0935612A1 Precursors of catalytic antibodies
08/18/1999EP0935610A1 Novel human interferon-inducible protein
08/18/1999EP0935607A2 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor
08/18/1999EP0935605A1 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof
08/18/1999EP0935601A2 Arylamino fused pyridines and pyrimidines
08/18/1999EP0935470A1 Method for treating allergic lung disease
08/18/1999EP0935465A1 Novel substituted imidazole compounds
08/18/1999EP0935463A2 Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
08/18/1999EP0896537B1 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide
08/18/1999EP0756489B1 Cyclosporin containing composition and process for the preparation thereof
08/18/1999EP0643726B1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
08/18/1999CN1226254A Method and composition useful for inhibition of vasculogenesis of alpha, beta medium
08/18/1999CN1226171A Type-2 chemokine binding proteins and methods of use thereof
08/18/1999CN1226170A Preparation of immunostimulating agents based in propionibacteria
08/18/1999CN1225822A Medicines and feed for fishes, shellfishes and animals and medicines for plants
08/17/1999US5939560 Inhibitors of DP-mediated processes, compositions and therapeutic methods thereof
08/17/1999US5939525 Methods of treating inflammation and compositions therefor
08/17/1999US5939452 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4' (LTB4) antagonists
08/17/1999US5939450 N,N-dimethyl-8,8-dipropyl-2-azaspiro 4.5!decane-2-propanamine dimaleate
08/17/1999US5939434 Tetrazolyl-substituted quinuclidines as substance P antagonists
08/17/1999US5939415 A!-annellated pyrrole derivatives and their use in pharmacology
08/17/1999US5939411 Piperidine derivatives substituted at position 4 with new functions other than those described previously have a high affinity for neurokinin receptors and are useful for treatment of substance p and neurokinin dependent pathologies
08/17/1999US5939409 Processes for the production of anti-inflammatory steroids
08/17/1999US5939400 DNA vaccination for induction of suppressive T cell response
08/17/1999US5939391 Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
08/17/1999US5939290 Modified sialyl Lewisx compounds
08/17/1999US5939286 Hybrid interferon tau/alpha polypeptides, their recombinant production, and methods using them
08/17/1999US5939283 Nucleotide sequences coding a protein that activates allergic responses
08/17/1999US5939073 Fish pancreatic disease virus
08/17/1999US5939069 Inhibiting the development of insulin dependent diabetes by administering indomethacin or n-2-cyclohexlyoxynitrophenyl methanesulfonamide
08/17/1999CA2076648C Composition for inducing humoral anergy to an immunogen
08/17/1999CA2008149C Fk-506 cytosolic binding protein
08/12/1999WO1999040220A2 Method of screening therapeutic agents
08/12/1999WO1999040201A1 Protein
08/12/1999WO1999040196A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
08/12/1999WO1999040187A1 Nucleic acids provided for modulating cellular activation
08/12/1999WO1999040184A1 Dendritic enriched secreted lymphocyte activation molecule
08/12/1999WO1999040183A1 Human serine protease and serpin polypeptides
08/12/1999WO1999040117A1 THREE-DIMENSIONAL STRUCTURES AND MODELS OF Fc RECEPTORS AND USES THEREOF
08/12/1999WO1999040115A2 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT
08/12/1999WO1999040113A2 Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions
08/12/1999WO1999040111A1 The aiolos gene
08/12/1999WO1999040104A1 Neokine protein and nucleic acid molecules and uses therefor
08/12/1999WO1999040091A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
08/12/1999WO1999040089A1 Benzothiadiazoles and derivatives
08/12/1999WO1999040085A1 Benzofuran-4-carboxamides and their therapeutic use
08/12/1999WO1999040083A2 Bifunctional tryptase inhibitors
08/12/1999WO1999040080A1 Hydroxamic and carboxylic acid derivatives
08/12/1999WO1999040073A2 Tryptase inhibitors
08/12/1999WO1999040069A1 Benzyloxy prodigiosine compounds
08/12/1999WO1999040061A2 Novel dihydroxyhexanoic acid derivatives
08/12/1999WO1999039739A1 Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media
08/12/1999WO1999039736A2 DELIVERY OF IMMUNOGENIC MOLECULES VIA HBsAg PARTICLES
08/12/1999WO1999039734A1 Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob
08/12/1999WO1999039733A1 Delivery method for recombinant raccoon poxvirus
08/12/1999WO1999039727A1 Costimulatory blockade and mixed chimerism in allotransplantation
08/12/1999WO1999039726A1 Costimulatory blockade and mixed chimerism in transplantation
08/12/1999WO1999039691A2 Pharmaceutical compositions
08/12/1999WO1999029339A3 Prevention and/or treatment of allergic conditions
08/12/1999WO1999025378A9 Immunoglobulin molecules having a synthetic variable region and modified specificity
08/12/1999WO1999022761A9 Conjugate heat shock protein-binding peptides
08/12/1999WO1999004820A3 Cytolysis of target cells by superantigen conjugates inducing t-cell activation
08/12/1999DE19803453A1 Vakzine Vaccine
08/12/1999DE19801265C1 Inhibierung von CD95-unabhängiger Apoptose bei AIDS Inhibiting CD95-independent apoptosis in AIDS
08/12/1999CA2751655A1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv)
1 ... 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 ... 1172